Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vaporox
The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT) for the treatment of Diabetic Foot Ulcers. VHT treatments will be provided as an adjunct to standard wound care. Subjects will receive VHT treatments until wound closure, or for the treatment period of 20 weeks.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diabetic foot wound, graded by the Wagner Scale as a 1,2 or 3
Wound has resisted healing with standard wound care for at least 6 weeks
No symptoms of sepsis
Able to maintain reasonable nutrition and hydration
Able to maintain adequate home care between treatment visits
Able to understand and follow basic wound care instructions, or has caregiver who can assist
You may not be if
Skin wounds cancer/neoplastic etiology
Wounds that involve osteomyelitis or tendon involvement
Diagnosis of methicillin resistant staph aureus by wound swab
Acute skin conditions
Surgery within 30 days of study onset
Wounds where the end cannot be probed
Participation in another clinical trial within 120 days prior to study onset
Non-compliant patients
Pregnancy
Presence of co-morbid conditions that in the physician's opinion exclude the individual from the study
Clareo Health | Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers
